FCER2 and mantle cell lymphoma: Before the anti-cyclin D1 antibody was widely available as a powerful tool to help distinguish MCL from CLL by flow cytometry, CD23 status had been considered very useful in separating CLL from MCL, especially when CD23 is either moderately.